Samsung Electronics closed July 30 at KRW 191,000 — but the question that now matters is whether the post-earnings re-rating has actually closed the gap, or merely narrowed it.
The previous two ORTEX notes framed the setup as a market that had priced in catastrophe. The July 30 Q2 print confirmed the bear case was wrong: operating profit up 23% year-on-year, memory pricing recovering, smartphone demand solid. The 26.5% single-day move that followed was the largest in years and erased weeks of damage. Yet even after that jump, the valuation picture remains striking. The trailing PE is approximately 2.7x. EV/EBITDA is near 1.7x. Price-to-book is 1.1x. These are not multiples that reflect a recovered stock — they reflect a stock that was priced for near-insolvency and has recovered to merely cheap. The 30-day change in PE is a compression of roughly 1.5 turns, driven entirely by the price move. The EPS earnings yield has risen to 37 cents on the dollar. For a company ranking in the 96th percentile on EV/EBIT and the 88th percentile on days-to-cover, the absolute valuation remains far below any reasonable reading of intrinsic worth.
The borrow market tells the same story it has told for months: shorts are essentially absent. Availability is at its structural ceiling. The fraction of the lending pool actually in use is negligible — effectively zero. Cost to borrow is running around 1%, unremarkable and unchanged from prior weeks. The ORTEX short score of 25.2, ranking in the 96th percentile for low short pressure, has barely moved all week. None of that changed on earnings day, and none of it has changed since. There is no short-covering dynamic to attribute to the move, and no new short-selling pressure emerging in its aftermath. The surge was driven by fundamental re-rating, not a squeeze.
The factor picture supports the bull case more than the valuation alone. EPS momentum over 30 and 90 days ranks in the 83rd and 91st percentiles respectively. The dividend score is in the 95th percentile — Samsung paid KRW 374 per preferred share in June and KRW 372 in March, with the next print due in October. Where the data hesitates is on forward earnings growth: the 12-month forward EPS year-on-year increase ranks only in the 13th percentile, a signal that the recovery in the current period may not project strongly into the next. The analyst rec differential score at 48 is neutral — not a ringing endorsement of acceleration.
Institutional ownership shows no sudden reshuffling. Samsung Life Insurance holds 7.6% of shares and trimmed fractionally. BlackRock added modestly at 5%. Capital Research built its position by nearly 7.8 million shares through June. Fidelity added 3.6 million. These are slow-moving, long-only flows — consistent with value-oriented investors who were positioned ahead of the print and are holding through the recovery. The largest notable change is Ra Hui Hong's 15 million share reduction, though the holder remains a top-ten name at just over 1.1% of the company.
The next scheduled earnings event is October 28. Between now and then, the story rotates from "will Samsung beat?" to "how durable is the memory recovery?" and "can the foundry segment close the gap on TSMC?" The EPS forward growth ranking at the 13th percentile is the data point worth watching — if forward estimates begin to move higher in line with the current-period beat, the valuation discount narrows further on its own. If they stall, the gap between KRW 191,000 and wherever analyst targets settle post-results revision becomes the defining tension for the next quarter.
See the live data behind this article on ORTEX.
Open A005935 on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
